TP Miller - Concepedia

Author

TP Miller

University of Arizona

Also Known As

T P Miller, T. P. Miller, TP Miller

Publications

Citations

H-Index

Concepts

All Affiliations

University of Arizona Arizona Oncology

About

TP Miller is an author at University of Arizona specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.6K
2	Health Sciences	6	6	939
3	Pharmacology	5	5	1.1K
4	Pathology	4	4	1.4K
5	Immunology	2	2	660

TP Miller

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. William S. Dalton, Thomas M. Grogan, Paul S. Meltzer, Journal of Clinical Oncology ImmunologyContinuous Infusion VerapamilPathologyPharmacotherapyImmunotherapy	1989	560
P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. TP Miller, Thomas M. Grogan, William S. Dalton, Journal of Clinical Oncology PathologyPharmacotherapyVerapamil ResultsTumor BiologyDrug Resistance	1991	385
Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. Dennis O. Dixon, Barbara A. Neilan, Siân Jones, Journal of Clinical Oncology Cancer ManagementPathologyPharmacotherapyMetronomic ChemotherapyImmunotherapy	1986	362
A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study R I Fisher, Steve Dahlberg, BN Nathwani, Blood	1995	347
Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial TP Miller, TM Grogan, Steve Dahlberg, Blood	1994	238
Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer SE Salmon, WS Dalton, TM Grogan, Blood	1991	227
Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67 TM Grogan, Lippman Sm, CM Spier, Blood	1988	225
Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement [see comments] W. F. Kern, CM Spier, EH Hanneman, Blood	1992	215
Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial TP Miller, TM Grogan, Steve Dahlberg, Blood	1994	206
Initial chemotherapy for clinically localized lymphomas of unfavorable histology TP Miller, SE Jones Blood	1983	197

Page 1